Medical Device Maker Alamar Bio Jumps 33% After Upsized US IPO

Alamar Biosciences raised $191 million in an upsized U.S. initial public offering priced at the top of its marketed range, and the shares climbed 33% on Friday. The strong debut suggests solid investor demand for the medical device maker. The move is positive for the company, though the broader market impact is limited.

Analysis

Alamar Biosciences raised $191 million in an upsized U.S. initial public offering priced at the top of its marketed range, and the shares climbed 33% on Friday. The strong debut suggests solid investor demand for the medical device maker. The move is positive for the company, though the broader market impact is limited.